SAT-163 Status at 10 Years: Long-Term Follow-Up for a Phase 2a Study of High-Specific-Activity (HSA) I 131 Iobenguane in Patients (Pts) with Relapsed/Refractory High-Risk Neuroblastoma

Background: Metaiodobenzylguanidine (MIBG; iobenguane), a guanethidine derivative, is a substrate for norepinephrine reuptake transporter which is highly expressed on the surface of neuroblastoma cells. AZEDRA® (HSA I-131 MIBG) has been approved by the FDA for the treatment of pheochromocytoma and p...

Descripción completa

Detalles Bibliográficos
Autores principales: Villablanca, Judith G, Maris, John M, Stambler, Nancy, Zhou, Duo, DiPippo, Vincent A, Matthay, Katherine K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Adrenal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207940/
http://dx.doi.org/10.1210/jendso/bvaa046.1293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207940/
http://dx.doi.org/10.1210/jendso/bvaa046.1293

Ejemplares similares